Mark Wurth – Grants & Contracts — University of Kentucky

View Scopus Profile

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

8 Finished
10 Active

18 results

Active

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Danov, Z., Anstead, M. & Wurth, M.
Vertex Pharmaceuticals Inc
9/2/22 → 5/25/23
Project: Research project
Covid-19: ROVER-An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of the mRNA-1273.214 Vaccine for SARS-CoV-2 Variants of Concern in Participants Aged 6 Months to < 6 Years
Fuchs, G., Bauer, J. & Wurth, M.
PPD Investigator Services LLC
8/8/22 → 6/6/23
Project: Research project
Cystic Fibrosis Center Program FY23 - Pediatrics Portion
Kanga, J., Danov, Z. & Wurth, M.
Cystic Fibrosis Foundation
7/1/22 → 6/30/23
Project: Research project
FY23 Metabolic Newborn Screening
Zarate, Y., Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.
KY Cabinet for Health and Family Services
7/1/22 → 6/30/24
Project: Research project
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Danov, Z., Anstead, M. & Wurth, M.
Vertex Pharmaceuticals Inc
6/16/22 → 4/12/23
Project: Research project
Therapeutic Development Center FY22
Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
Cystic Fibrosis Foundation
4/1/22 → 3/31/23
Project: Research project
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease
Wurth, M. & Ballard, H.
Merck Sharp & Dohme Corporation
3/1/22 → 7/15/23
Project: Research project
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del or Heterozygous for F508del and a Gating (F/G) or Residual Function (F/R
Danov, Z., Anstead, M., Garrett, N. & Wurth, M.
Vertex Pharmaceuticals Inc
9/1/21 → 5/25/23
Project: Research project
Covid 19: A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Oberver-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine
Fuchs, G., Bauer, J., Desai, N., Greenberg, R., Robbins, S., Simmons, C. & Wurth, M.
PPD Investigator Services LLC
6/16/21 → 1/7/24
Project: Research project
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study)
Wurth, M., Anstead, M. & Pancham, K.
Seattle Childrens Research Institute
11/1/18 → 6/14/23
Project: Research project
Finished
Cystic Fibrosis Center Program FY22 - Pediatrics Portion
Kanga, J., Danov, Z. & Wurth, M.
Cystic Fibrosis Foundation
7/1/21 → 6/30/22
Project: Research project
Cystic Fibrosis Center Program FY21 - Pediatrics Portion
Kanga, J., Danov, Z., Marsac, M., Pancham, K. & Wurth, M.
Cystic Fibrosis Foundation
7/1/20 → 6/30/21
Project: Research project
FY21 UK Metabolic Newborn Screening
Day, S., Kahler, S., Kanga, J., Radulescu, V., Thrailkill, K. & Wurth, M.
KY Cabinet for Health and Family Services
7/1/20 → 6/30/21
Project: Research project
FY22 UK Metabolic Newborn Screening
Day, S., Fowlkes, J., Kahler, S., Kanga, J., Radulescu, V. & Wurth, M.
KY Cabinet for Health and Family Services
7/1/20 → 6/30/22
Project: Research project
FY20 Metabolic Newborn Screening
Psychogios, A., Fowlkes, J., Kanga, J., Radulescu, V. & Wurth, M.
KY Cabinet for Health and Family Services
7/1/18 → 6/30/20
Project: Research project
Therapeutic Development Center FY2022
Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
Cystic Fibrosis Foundation
1/1/14 → 3/30/22
Project: Research project
Cystic Fibrosis Center Program 2019-2020 (PEDS Portion)
Kanga, J., Danov, Z., Pancham, K. & Wurth, M.
Cystic Fibrosis Foundation
7/1/13 → 6/30/19
Project: Research project
Cystic Fibrosis FY 20 - Pediatrics Portion
Kanga, J., Danov, Z., Pancham, K. & Wurth, M.
Cystic Fibrosis Foundation
7/1/13 → 6/30/20
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.